Xanthohumol and Gossypol Are Promising Inhibitors against Babesia microti by In Vitro Culture via High-Throughput Screening of 133 Natural Products

Human babesiosis caused by Babesia microti is an emerging threat for severe illness and even death, with an increasing impact worldwide. Currently, the regimen of atovaquone and azithromycin is considered as the standard therapy for treating human babesiosis, which, however, may result in drug resis...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jiaying, Luo, Xiaoying, Wang, Sen, He, Lan, Zhao, Junlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711813/
https://www.ncbi.nlm.nih.gov/pubmed/33081295
http://dx.doi.org/10.3390/vaccines8040613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711813/
https://www.ncbi.nlm.nih.gov/pubmed/33081295
http://dx.doi.org/10.3390/vaccines8040613

Ejemplares similares